NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Western District of Texas on behalf of all persons and entities who purchased or otherwise acquired securities of (a) agilon health, inc. ("agilon" or the "Company") (NYSE:AGL) common stock between January 9, 2023 and January 4, 2024, both dates inclusive (the "Class Period"); and/or (b) agilon common stock pursuant and/or traceable to the Company's May 2023 secondary public offering (the "SPO").
The Complaint alleges that, throughout the Class Period and in the SPO Materials, Defendants misled investors about agilon's medical costs by: (i) touting the Company's purported visibility into utilization trends and medical costs; (ii) failing to ...
AGL)>Full story available on Benzinga.com